News
The FDA approved Abbott's Tendyne minimally invasive heart replacement for mitral valve disease that could disqualify ...
The approval is tightly defined: the system will be for patients ineligible for surgery and with anatomy unfavorable for TEER ...
Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Tendyne™ transcatheter mitral valve replacement (TMVR) system to treat people with mitral ...
Abbott (NYSE: ABT) announced today that it received FDA approval for its Tendyne transcatheter mitral valve replacement (TMVR ...
8d
GlobalData on MSNFDA approves Abbott’s TMVR system to treat mitral valve diseaseThe system is available for patients whose mitral valves are not working properly due to severe mitral annular calcification.
The FDA gave the OK for the North Chicago-based medical device maker's Tendyne transcatheter mitral valve replacement.
The Tendyne system is designed for those who are considered high-risk for traditional open-heart surgery and for whom mitral valve repair with Abbott’s MitraClip is not a viable option.
8d
MedPage Today on MSNTendyne TMVR Gets FDA Nod; Breastfeeding and ASCVD; Sudden Bodybuilder DeathsAbbott's Tendyne transcatheter mitral valve replacement (TMVR) system was approved by the FDA and indicated for those with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results